Immunovantinc Stock Piotroski F Score
| IMVT Stock | USD 28.80 0.19 0.66% |
ImmunovantInc | Piotroski F Score |
At this time, it appears that ImmunovantInc's Piotroski F Score is Very Weak. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
1.0
Piotroski F Score - Very Weak
| Current Return On Assets | Negative |
| Change in Return on Assets | Decreased |
| Cash Flow Return on Assets | Negative |
| Current Quality of Earnings (accrual) | Decreasing |
| Asset Turnover Growth | No Change |
| Current Ratio Change | Decrease |
| Long Term Debt Over Assets Change | N/A |
| Change In Outstending Shares | Increase |
| Change in Gross Margin | No Change |
ImmunovantInc Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to ImmunovantInc is to make sure ImmunovantInc is not a subject of accounting manipulations and runs a healthy internal audit department. So, if ImmunovantInc's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if ImmunovantInc's financial numbers are properly reported.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Current Liabilities | 52.3 M | 49.8 M |
|
| |||||
| Non Current Liabilities Total | 40.2 K | 42.3 K |
|
| |||||
| Total Assets | 264.7 M | 466.7 M |
|
| |||||
| Total Current Assets | 263.2 M | 465 M |
|
|
ImmunovantInc F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between ImmunovantInc's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards ImmunovantInc in a much-optimized way.
| -0.61 | 0.64 | -0.16 | 0.6 | 0.6 | 0.17 | ||
| -0.61 | -0.91 | -0.01 | -0.98 | -0.98 | 0.25 | ||
| 0.64 | -0.91 | 0.0 | 0.89 | 0.89 | -0.41 | ||
| -0.16 | -0.01 | 0.0 | 0.02 | 0.02 | 0.45 | ||
| 0.6 | -0.98 | 0.89 | 0.02 | 1.0 | -0.26 | ||
| 0.6 | -0.98 | 0.89 | 0.02 | 1.0 | -0.26 | ||
| 0.17 | 0.25 | -0.41 | 0.45 | -0.26 | -0.26 |
Click cells to compare fundamentals
About ImmunovantInc Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
About ImmunovantInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ImmunovantInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmunovantInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmunovantInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ImmunovantInc Investors Sentiment
The influence of ImmunovantInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ImmunovantInc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ImmunovantInc's public news can be used to forecast risks associated with an investment in ImmunovantInc. The trend in average sentiment can be used to explain how an investor holding ImmunovantInc can time the market purely based on public headlines and social activities around ImmunovantInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ImmunovantInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ImmunovantInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ImmunovantInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ImmunovantInc.
ImmunovantInc Implied Volatility | 78.88 |
ImmunovantInc's implied volatility exposes the market's sentiment of ImmunovantInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ImmunovantInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ImmunovantInc stock will not fluctuate a lot when ImmunovantInc's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunovantInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunovantInc's short interest history, or implied volatility extrapolated from ImmunovantInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ImmunovantInc Altman Z Score, ImmunovantInc Correlation, ImmunovantInc Valuation, as well as analyze ImmunovantInc Alpha and Beta and ImmunovantInc Hype Analysis. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for ImmunovantInc Stock analysis
When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.